Resource use and costs associated with patients treated for depression in primary care |
| |
| Authors: | P. Sobocki M. Ekman H. Ågren I. Krakau B. Runeson B. Mårtensson B. Jönsson |
| |
| Affiliation: | 1.Department of Learning, Informatics, Management and Ethics, Medical Management Centre,Karolinska Institutet,Stockholm,Sweden;2.Stockholm Health Economics,Stockholm,Sweden;3.Division of Psychiatry,Karolinska University Hospital,Huddinge,Sweden;4.Department of Medicine, Section for General Medicin,Karolinska Institutet,Solna,Sweden;5.Karoliniska Institutet, Department of Clinical Neuroscience, Section for Psychiatry,St G?ran’s Hospital,Stockholm,Sweden;6.Department of Clinical Neuroscience,Karolinska Institutet,Stockholm,Sweden;7.Stockholm School of Economics,Stockholm,Sweden |
| |
| Abstract: | We investigated medical resource consumption, productivity loss and costs associated with patients treated with antidepressants for depression in primary care in Sweden. Patients on treatment for depression were followed naturalistically for six months, and data on patients’ characteristics, daily activity and resource-use were collected. The total cost per patient was estimated at € 5,500 (95%CI € 5,000—6,100) over six months in 2005 prices. Direct costs were estimated at € 1,900 (€ 1,700–2,200), 35% of total costs, and indirect costs at € 3,600 (€ 3,100–4,100), 65% of total costs. The cost for antidepressants represented only 4% of the total costs. We conclude that the burden of depression is high, both to the individual as well as to wider society, and there seems to be a particular need for therapies that have the potential to improve productivity in depressed patients. |
| |
| Keywords: | Depression Primary care Cost Cost of illness |
| 本文献已被 SpringerLink 等数据库收录！ |
|
